Neuroimmunologische Aspekte funktioneller somatischer Syndrome

Glossar

ACTH = Adrenokortikotropes Hormon

ANS = Autonomes Nervensystem

aMSH = ALPHA-Melanozyten stimulierendes Hormon

AVP = Arginin-Vasopressin

CRH = Corticotropin releasing Hormon

FSH = Follikelstimulierendes Hormon

HPA = Hypothalamus-Hypophysen-Nebennieren-Achse

HPG = Hypothalamus-Hypophysen-Gonaden-Achse

HPS = Hypothalamus-Hypophysen-Wachstums-Achse

HPT = Hypothalamus-Hypophysen-Schilddrüsen-Achse

LC = Locus coeruleus

LH = Luteiniserendes Hormon

LHRH = Luteinisierendes Hormon Releasing Hormon

NE = noradrenerge Neurone

NFG = Nerve growth Factor

NPY = Neuropeptid Y

PVN = paraventrikulärer Nukleus

VIP = vasoaktives intestinales Peptid

Literatur

• 1 Aaron L A, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions.  Ann Intern Med. 2001;  134 868-881
• 2 Ader R. Conditioned immunomodulation: Research needs and directions.  Brain Behavior and Immunity. 2003;  17 S51-S57
• 3 Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions.  Ann Med. 2003;  35 2-11
• 4 Arlt W, Callies F, van Vlijmen J C. et al . Dehydroepiandrosterone replacement in women with adrenal insufficiency.  New Engl J Med. 1999;  341 1013-20
• 5 Barsky A J, Borus J F. Functional somatic syndromes.  Ann Intern Med. 1999;  130 910-921
• 6 Bedoui S, Kawamura N, Straub R H, Pabst R, Yamamura T, von Hörsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk.  J Neuroimmunol. 2003;  134 1-11
• 7 Bennett R M. Adult growth hormone deficiency in patients with fibromyalgia.  Curr Rheumatol Reports. 2002;  4 306-312
• 8 Benoist C, Mathis D. Mast cells in autoimmune disease.  Nature. 2002;  420 875-878
• 9 Berg P A. Chronisches Müdigkeits- und Fibromyalgiesyndrom. 2nd ed Berlin, Heidelberg, New York: Springer In: Berg PA, editor. Chronisches Müdigkeits- und Fibromyalgiesyndrom. Manifestation einer generalisierten neuroregulativen Funktionsstörung 2003: 3-24
• 10 Berg P A, Klein R. Fibromyalgie-Syndrom. Eine neuroendokrinologische Erkrankung.  Dtsch Med Wochenschr. 1994;  119 424-435
• 11 Borda T, Perez Rivera R, Joensen L, Gomez R M, Sterin-Borda L. Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction.  J Immunol. 2002;  168 3667-3674
• 12 Boudarene M, Legros J J, Timsit-Berthier M. Study of the stress response: role of anxiety, cortisol and DHEAs.  Encephale. 2002;  28 139-146
• 13 Capuron L, Dantzer R. Cytokines and depression: The need for a new paradigm.  Brain, Behavior and Immunity. 2003;  17 S119-S124
• 14 Caspi A, Sugden K, Moffitt T E. et al . Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.  Science. 2003;  301 386-389
• 15 Chrousos G P, Gold P W. The concepts of stress and stress system disorders.  JAMA. 1992;  267 1244-1252
• 16 Cleare A J. The neuroendocrinology of chronic fatigue syndrome.  Endocrine Rev. 2003;  24 236-252
• 17 Crofford L J, Clauw D J. Fibromyalgia: Where are we a decade after the american college of rheumatology classification criteria were developed?.  Arthritis Rheum. 2002;  46 1136-1138
• 18 Csef H. Funktionelle (somatoforme) Störungen beim internistischen Hausbesuch.  Internist. 2001;  42 1476-1487
• 19 Demitrack M A, Crofford L J. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome.  Ann N Y Acad Sci. 1998;  840 684-697
• 20 Egle U T, Egle-Ecker M -L, Nickel R, van Hodenhove B. Fibromyalgie als Störung der zentralen Schmerz- und Stressverarbeitung.  Psychother Psych Med. 2003;  53 1-11
• 21 Elenkov I J, Chrousos G P, Wilder R L. Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications.  Ann N Y Acad Sci. 2000;  917 94-105
• 22 Eskandari F, Sternberg E M. Neural-immune interactions in health and disease.  Ann N Y Acad Sci. 2002;  966 20-27
• 23 Fetissov S O, Hallman J, Oreland L. et al . Autoantibodies against (-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients.  Proc Natl Acad Sci USA. 2002;  99 17155-17160
• 24 Haas H S, Schauenstein K. Neuroimmunomodulation via limbic structures - the neuroanatomy of psychoimmunology.  Prog Neurobiol. 1997;  51 195-222
• 25 Hocevar A, Tomic M, Praprotnik S, Hojnik M, Kveder T, Rozman B. Parasympathketic nervous system dysfunction in primary Sjögren’s syndrome.  Ann Rheum Dis. 2003;  62 702-704
• 26 Hróbjartsson A, Gøtzsche P C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.  N Engl J Med. 2001;  344 1594-1602
• 27 Jones T H, Wadler S, Hupart K H. Endocrine-mediated mechanisms of fatigue during treatment with interferon-α.  Sem Oncol. 1998;  25 54-63
• 28 Klein R, Berg P A. High incidence of antibodies to 5-Hydroxytryptamine, gangliosides and phosphlipides in patients with chronic fatigue syndrome and their relatives. Evidence for a clinical entity of both disorders.  Eur J Med Res. 1995;  1 21-26
• 29 Konsman J P, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications.  Trends Neurosciences. 2002;  25 154-159
• 30 Libert C. A nervous connection.  Nature. 2003;  421 328-329
• 31 Lotti T, Bianchi B, Ghersetich I, Brazzini B, Hercogova J. Can the brain inhibit inflammation generated in the skin? The lesson of α-melanocyte- stimulating hormone.  Int J Dermatol. 2002;  41 311-318
• 32 Maeda K, Yasuda M, Kaneda H, Maeda S, Yamadovi A. Cerebrospinal fluid (CFS) neuropeptide (- and somatostatin like immunoreactivities in man.  Neuropeptides. 1994;  27 323-332
• 33 Marshall J S, Mc Curdy J D, Olynch T. Toll-like receptor-mediated activation of mast cells: implications for allergic disease?.  Int Arch Allergy Immunol. 2003;  132 87-97
• 34 McEwen B S, Alves S H. Estrogen actions in the central nervous system.  Endocr Rev. 1999;  20 279-307
• 35 Mönnikes H, Tebbe J J, Hildebrandt M. et al . Role of stress in functional gastrointestinal disorders.  Dig Dis. 2001;  19 201-211
• 36 Musselman D L, Lawson D H, Gumnick J F. et al . Paroxetine for the prevention of depression induced by high-interferon alfa.  N Engl J Med. 2001;  344 961-966
• 37 Narita M, Nishigami N, Narita N. et al . Association between serotonin transporter gene polymorphism and chronic fatigue syndrome.  Biochem Biophys Res Commun. 2003;  311 264-266
• 38 Neumann L, Buskila D. Epidemiology of fibromyalgia.  Curr Pain Headache Rep. 2003;  7 362-386
• 39 Nguyen V T, Ndoye A, Grando S G. Novel human a9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity.  Am J Pathol. 2000;  157 1377-1391
• 40 Offenbaecher M, Bondy B, de Jonge S. et al . Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region.  Arthritis Rheum. 1999;  42 2482-2488
• 41 Pavia E S, Deodhar A, Jones K D, Bennett R. Impaired growth hormone secretion in fibromyalgia patients.  Arthritis Rheum. 2002;  46 1344-1350
• 42 Roth J, LeRoith D, Shiloach J, Rosenzweig J L, Lesniak M A, Havrankova J. The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers.  New Engl J Med. 1982;  306 523-527
• 43 Schauenstein K, Rinner I, Felsner P, Stevenson R, Haas H, Liebmann P. Mens sana in corpore sano - and vice versa. The role of the autonomic nervous system in the immune-neuroendocrine dialogue.  Int J Hyg Environ Health. 2001;  204 75-79
• 44 Sherman J J, Turk D C, Okifuji A. Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome.  Clin J Pain. 2000;  16 127-134
• 45 Spiller R C. Postinfectious irritable bowel syndrome.  Gastroenterology. 2003;  124 1662-1671
• 46 Sternberg E M. Neural-immune interactions in health and disease.  J Clin Invest. 1997;  100 2641-2647
• 47 Straub R H, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis.  Arthritis Rheum. 2001;  44 493-507
• 48 Suzuki R, Furuno T, McKay D M. et al . Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P.  J Immunol. 1999;  163 2410-2415
• 49 Tanaka S, Matsunaga H, Kimura M. et al . Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.  J Neuroimmunol. 2003;  141 155-164
• 50 Tanriverdi F, Silverira L FG, Mac Coll G S, Bouloux P MG. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity.  J Endocrinol. 2003;  176 293-304
• 51 Torpy D J, Bachmann A W, Grice J E. et al . Familial corticosteroid-binding globulin deficiency due to a novel null muttation: association with fatigue and relative hypotension.  J Clin Endocrinol Metab. 2001;  86 3692-3700
• 52 Tracey K J. The inflammatory reflex.  Nature. 2002;  420 853-859
• 53 Tsigos C, Chrousos G P. Hypothalamic-pituitary-adrenal axis: neuroendocrine factors and stress.  J Psychosom Res. 2002;  53 865-871
• 54 Wang H, Yu M, Ochani M. et al . Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation.  Nature. 2003;  421 384-388
• 55 Watkins L R, Maier S F. Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states.  Physiol Rev. 2002;  82 981-1011
• 56 Yehuda R. Post-traumatic stress disorder.  N Engl J Med. 2002;  346 108-114